Case Clinic Challenge: A Young Woman Who Wants to Stop Her Bipolar Medication Due to Side Effects

Evidence-Based Therapies for Bipolar Depression: Making Informed Treatment Decisions
0.5 AMA PRA Category 1 Credit(s)
Launch Date:
January 28, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Psychiatrists, nurse practitioners, physician assistants, and other healthcare professionals working in a specialty setting who manage patients with bipolar depression.

Relevant Terms:

Bipolar Depression

W. Clay Jackson, MD, DipTh, FAAFP

W. Clay Jackson, MD, DipTh, FAAFP
Clinical Assistant Professor of Family Medicine & Psychiatry
University of Tennessee College of Medicine
Memphis, TN

Dr. Jackson is a Clinical Assistant Professor of Family Medicine and Psychiatry at the University of Tennessee College of Medicine in Memphis, Tennessee, where he maintains a private practice in family and palliative medicine. He is Medical Director of Comprehensive Primary Care and Medical Director for Methodist Hospice and Palliative Services, also in Memphis. In addition, Dr. Jackson is the Fellowship Director for Palliative Medicine at the University of Tennessee College of Medicine. From this professional platform, he has led a team of dedicated clinicians who have helped to transform the experience of seriously ill patients in the Mid-South.
Dr. Jackson earned his bachelor of science degree in biology and chemistry at Union University in Jackson, Tennessee, and his diploma in theology at Oxford University in England. He is a Fellow of the American Academy of Family Physicians, holds a Certificate of Added Qualification in Hospice and Palliative Medicine, and is a member of the Alpha Omega Alpha Medical Honor Society.
Dr. Jackson has been the recipient of numerous clinical and teaching awards and has had his research published in numerous journals, including Family Medicine, Journal of Affective Disorders, and the Journal of the American Medical Association. A frequently invited speaker at national and international professional meetings, he has also been featured in several multimedia projects concerning the treatment of affective disorders and chronic pain as well as the history and philosophy of medicine.
Outside medicine, his interests include an active outdoor lifestyle, literature, music, and theology. His most fulfilling role, without a doubt, is being a dad to his son Wesley. Dr. Jackson believes in Memphis as a place where grit meets grace.
1. Construct individualized, evidence-based treatment plans for patients with bipolar I depression, assessing the data for approved and nonapproved therapies
2. Employ strategies for a patient-centric approach and more effective patient/caregiver communication with regard to treatment options, adherence, and improving outcomes and quality of life

Provided by Haymarket Medical Education
Supported by an educational grant from Sunovion Pharmaceuticals Inc.
Program Description  
Patients with bipolar disorder spend more time in depression than mania or hypomania and tend to seek treatment during depressive episodes more often than during manic periods. There is often a discrepancy between real-world management of bipolar depression and evidence-based recommendations. Treating patients with bipolar depression ideally requires a partnership between the patient and the clinician, including shared decision-making. This interactive case highlights data-supported treatment options and effective patient dialogues that can help identify and respond to the patient’s individual needs and improve outcomes for bipolar depression. 
Disclosure of Conflicts of Interest Statement
In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Disclosures are as follows:
W. Clay Jackson, MD, DipTh, FAAFPConsultant: Forest, Merck, Otsuka, Sunovion Pharmaceuticals Inc., Takeda. Speakers Bureau: Sunovion Pharmaceuticals Inc. Ownership Interest: Aspire Healthcare.

The staff, planners, and reviewer at Haymarket Medical Education have no relevant financial relationships to disclose.

Accreditation/Designation of Credit Statement
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only those credits commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Sunovion Pharmaceuticals Inc. and HME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Sunovion Pharmaceuticals Inc. and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Method of Participation 
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

Contact Information
If you have any questions relating to the accreditation of this activity, please contact Julie A. Tagliareni at 

Privacy Policy

Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1     
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above